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Background. Co-morbid depression is common in people with tuberculosis (TB). Symptoms of depression (low energy,
impaired concentration, decreased motivation and hopelessness) may affect help-seeking; however, this impact has not
been studied so far. The objectives of this study were to assess the impact of co-morbid depression on diagnostic delay,
pathways to care, and to identify if it mediates other factors associated with diagnostic delay.
Methods. We analyzed cross-sectional data collected from 592 adults with newly diagnosed TB. We assessed probable
depression using Patient Health Questionnaire, nine items (PHQ-9) at a cut-off 10. Data on diagnosis delay, pathways to TB
care, socio-demographic variables, stigma, types of TB, substance use, co-morbid chronic illnesses, and perception about TB
were assessed using a structured questionnaire. Generalized structural equation modelling was used to analyze the data.
Results. A total of 313 (52.9%) participants had probable depression. Pathway to TB care was direct for 512 (86.5%) of
the participants and indirect for 80 (13.5%) of them. The median diagnosis delay was 12.0 weeks. Depression did not
have a statistically significant association with pathways to TB care (β =−0.45; 95% CI−1.85 to 0.96) or diagnostic
delay [adjusted odds ratio (AOR) = 0.90; 0.77–1.06]. Indirect pathway to TB care was positively associated with diagnosis
delay (AOR = 2.72; 95% CI 1.25–5.91).
Conclusions. People with TB who had co-morbid probable depression visited the modern health care as directly as and
as soon as those without co-morbid depression. How socio-demographic factors influence pathways to care and diagno-
sis delay require qualitative exploration.
Received 31 December 2018; Revised 11 July 2019; Accepted 29 July 2019
Key words: Depression, diagnosis-delay, Ethiopia, pathways-to-care, tuberculosis.
Introduction
Tuberculosis (TB) is one of the leading causes of death
from an infectious disease in the world (World Health
Organization, 2018) and the third highest contributor
to disability adjusted life years (DALYS) in Ethiopia
(GBD 2016 DALYS and HALE Collaborators, 2017).
Timely diagnosis and correct treatment cure most peo-
ple who develop TB (World Health Organization,
2016). Delayed diagnosis leads to more severe clinical
presentations (Virenfeldt et al., 2014), longer duration
of infectivity and poorer prognosis. Rapid diagnosis
is essential in order to decrease the incidence rate of
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TB (Friedland, 2011) to the extent required to meet the
Global End-TB target by the year 2030 (10% decrease/
year) (World Health Organization, 2015). Delayed
diagnosis of TB has been found to be associated with
HIV status, residence, geographical or socio-
psychological barriers, health care provider contacted
upon seeing symptoms, type of TB, age, sex, substance
use, level of education, and stigma (Storla et al., 2008).
Many of these variables are known to be associated
with depression in people with TB (Ambaw et al.,
2017); but the impact of co-morbid depression on diag-
nostic delay has not been investigated (Storla et al.,
2008).
Co-morbid depression, a common disorder in people
with TB (Trenton & Currier, 2001; Doherty et al., 2013;
Sweetland et al., 2014; Sweetland et al., 2017, 2018),
may negatively affect timely diagnosis and service util-
ization (Sweetland et al., 2018). People with depression
are known to have poor service utilization even in
high-income settings (Andrews et al., 2001; Oliver
et al., 2005). Depression is associated with reduced
energy levels, impaired concentration and memory,
low motivation and hopelessness (Katon, 2011).
Co-morbid depression could also obscure recognition
of TB symptoms because of the overlap of symptoms
of depression with physical illnesses (Pachi et al.,
2013) and predominantly vague somatic presentation
of depression (Keely et al., 2004). Impaired uptake of
health education messages may also lead to more
indirect pathways to TB care (e.g. via traditional and
religious healing), which in turn has been shown to
result in diagnostic delay (Finnie et al., 2011).
The aim of this study was to assess the association
between depression and diagnosis delay, pathways to
TB care, and its role in mediating the association
between diagnosis delay and the known risk factors
in people with TB. Our hypotheses were as follows:
(1) Co-morbid depression will be associated with
delayed diagnosis in people with TB and may be
a mediator of the effects of known risk factors for
diagnostic delay.
(2) Co-morbid depression in people with TB will inter-
fere with effective help-seeking and greater use of
indirect pathways to care.
Methods
Design
We analyzed cross-sectional data focusing on time to
TB diagnosis, pathways to TB care, and depression
from the baseline of our cohort study investigating
the impact of co-morbid depression on TB outcomes
in primary care settings in Ethiopia. In that cohort
study, adults with newly diagnosed TB were recruited
at the time of initiating Directly Observed Treatment
Short-Course (DOTS) and followed up to the end of
treatment (6 months after initiation). Data were col-
lected at three time-points: baseline (before anti-TB
treatment), at 2 months (end of intensive phase) and
at 6 months (end of continuation phase). The exposure
variable was depression. The primary outcome vari-
able was TB treatment outcomes (treatment complete,
cure, treatment failure, treatment default, or death).
Secondary outcome variables were quality of life, dis-
ability, and pathways to TB care. Control variables
included socio-demographic variables, substance use,
perceived social support, perceived cause of TB, per-
ceived barriers to modern TB care, stigma related to
TB, and perceived severity of TB (Ambaw et al., 2015).
Study setting
The study was conducted from December 2014 to July
2016 in 14 primary care centres in South central
Ethiopia (the Silti and Gurage zones) and northern
Ethiopia (Bahir Dar zone). Two of the primary care
centres were hospitals and 12 were health centres.
Similar TB services were provided at the different
types of facility: providers of TB care were nurses or
public health officers, the same treatment guidelines
and medications were used, and only outpatients
were included. The frontline nurses and public health
officers working in those primary care centres had
received training in the management of mental disor-
ders according to the evidence-based WHO Mental
health gap action programme intervention guide
(mhGAP-IG) for mental, neurological and substance
use disorders in non-specialized health care settings
(WHO, 2016).
Eligibility criteria
• People attending the selected health centres for TB
treatment who were within 1 month of starting
anti-TB treatment
• Aged 18 years and above
• Did not have plan to move out of the study area
• Not too ill to be interviewed at baseline as perceived
by the interviewer or the prospective participant
• Were not admitted to in-patient unit for more than 5
days in the last 1 month as the additional stressors of
being hospitalized represent a different range of risk
factors for depression.
• Did not have Multidrug-Resistant Tuberculosis
(MDR-TB); people with MDR-TB constitute a differ-
ent population because their treatment and out-
comes are different (more toxic medications for a
much longer duration and poorer prognosis) and
MDR-TB is a more feared and stigmatized condition
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(Vega et al., 2004). Furthermore, only one of the
study health facilities had recently started a service
for people with MDR-TB.
• Were not on re-treatment for TB as people who
experienced previous treatment failures are at high
risk of MDR-TB and constitute a different risk
group for depression.
Sample size determination
The sample size was based on the primary objective of
the longitudinal study which was to examine the effect
of depression on default from anti-TB treatment
(Ambaw et al., 2015). The following parameters were
used in that calculation: 80% power, 95% confidence
level, 2.5% prevalence of treatment default among
patients with TB and without depression, 7.5% preva-
lence of treatment default among people with TB and
co-morbid depression, a ratio of 2:1 of non-exposed
(not depressed) to exposed (depressed) participants.
This provided a required sample size of 639. With a
contingency of 10% (64) for possible loss to follow
up, the target sample was 703 people with TB.
However, only 657 people with newly diagnosed TB
were recruited into the study because of the scarcity
of cases that meet our selection criteria (Ambaw
et al., 2017). Because one of the required variables,
stigma, was measured at 2 months of follow up, 65
(25 transferred out of study area, 22 died, nine diagno-
ses changed, six lost to follow up, and three refused to
participate in the second month) of the 657 participants
did not have value for it (Ambaw et al., 2018).
Therefore, we analyzed data from the remaining 592
participants who had complete responses for the vari-
ables of interest for this study.
Recruitment and ethics
People with newly diagnosed TB who fulfilled the
inclusion criteria were identified, informed and invited
to participate in the study by health professionals run-
ning TB clinics at the health facilities. When the indivi-
duals expressed interest to participate, they were
linked to trained nurse research assistants who pro-
vided them detail information, sought written
informed consent or witnessed thumb print, and car-
ried out the data collection generally at the health facil-
ities. The information provided to participants was
explained face-to-face and delivered in written form
to participants. The proposal was approved by the
Institutional Review Board of College of Health
Sciences of Addis Ababa University (number 027/14/
Psy) before data collection. In the process of data col-
lection, respondents who endorsed the suicide item
of PHQ-9 were referred to health workers within the
health facilities for further evaluation and treatment.
Dependent variables
Diagnostic delay
Diagnostic delay was defined as the time interval
between the onset of TB symptoms and diagnosis of
TB (Belay et al., 2012). Participants were asked ‘how
long did your TB symptoms last before your illness
was diagnosed as TB?’ In this study, the diagnosis
was considered to be ‘delayed’ if the interval between
the onset of symptoms and the date of diagnosis was
above 12 weeks. Because there was no standard defin-
ition for diagnosis delay, the median of the sample
scores (12 weeks) was used as a cut off value to oper-
ationally define the variable. A systematic review had
found out that previous quantitative studies com-
monly used the median split to define delay (Finnie
et al., 2011).
Pathways to TB care
This was measured using a modified version of the
World Health Organization (WHO) encounter form
for mental disorders (WHO, 1987). Pathway to TB
care was categorized as ‘direct’ if people with TB dir-
ectly contacted the modern health care system where
TB symptoms were recognized for the current illness
episode. Pathways were categorized as ‘indirect’ if par-
ticipants indicated that they had sought help from the
traditional health care system prior to attending bio-
medical services.
Independent variables
Probable depression:
Depression was an independent variable hypothesized
to be associated with both pathways to TB care and
diagnosis delay. It was also considered as a mediator
of the relationship between other independent vari-
ables and the dependent variables. Probable depres-
sion was measured using the nine-item version of the
Patient Health Questionnaire (PHQ-9). Globally, the
scale has been widely used in surveys, effectiveness
trials and cohort studies (Kroenke et al., 2010). In
Ethiopia, it has been validated in two settings and
was found to be useful in screening depression in
adult outpatients (Gelaye et al., 2013; Hanlon et al.,
2015). The optimum cut-off point was five and above
in primary healthcare centres in a rural district
(Hanlon et al., 2015) and ten and above in outpatient
medical clinics in a referral hospital in Addis Ababa
(Gelaye et al., 2013). We applied the more conservative
cut-off point of ten and above to define probable
depression given the potential overlap between TB
and depression symptoms. The baseline data of this
study indicated that the PHQ-9 had a single-
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dimensional structure, Cronbach’s alpha of 0.81, and a
mean inter-item correlation coefficient of 0.33 (Ambaw
et al., 2017). In this paper, the term depression is used
instead of probable depression for simplicity.
Socio-demographic variables
Age, sex, marital status, level of education, religion,
household income, occupation and place of residence
(urban v. rural) were measured by self-report.
Household income was measured by asking the parti-
cipants to estimate the monthly total income of their
household. When the participant was a farmer, we
changed the estimates of annual income in kind to
cash using the local market price. We converted the
monthly income into annual income.
Substance use
Alcohol, tobacco and khat use were measured using the
WHO Alcohol, Smoking and Substance Involvement
Screening Test (ASSIST) (version 3.1) (WHO, 2010a).
ASSIST was designed for use across different cultural
settings. The instrument’s psychometric properties
have been tested using data from multiple countries,
including low, middle, and high-income countries and
shown to be valid, reliable and easy to administer across
settings (Humeniuket al., 2008).
Perceived social support: Perceived social support was
measured using the three-item Oslo Scale of Perceived
Social Support with scores ranging from 3 to 14
(Meltzer, 2003). The scale was previously reported to
work well in Ethiopia in TB patients (Duko et al.,
2015). The total score was categorized in tertiles
which were then operationalized as poor, moderate
and strong perceived social support.
Co-morbid illness
Data on the presence of chronic illnesses other than TB
were obtained by asking the question ‘Have you ever
been told by health professionals that you have cardiac
illness, hypertension, diabetes mellitus, depression or
mental illnesses other than depression?’ HIV status
was recorded from the TB register.
Type of TB (pulmonary or extra-pulmonary)
Information extracted from the TB register in the health
facilities.
Disability
Disability was measured using the interviewer admi-
nistered version of the 12-item World Health
Organization Disability Assessment Schedule, version
2.0 (WHODAS 2.0) (WHO, 2010b). Studies have
demonstrated the usefulness of the tool for assessing
disability in primary care patients with depression
(Chwastiak & Von Korff, 2003). The scale has been pre-
viously used in Ethiopia (Mogga et al., 2006; Senturk
et al., 2012; Habtamuet al., 2017). Scores were divided
into tertiles and operationalized as no or low disability,
moderate and severe disability.
Perceptions about TB
Perceived severity of TB, perceived benefits of TB treat-
ment, perceived barriers to modern TB treatment and
perceived causes of TB were captured by asking the
respondents, ‘How severe do you think TB is (mild,
moderate or severe), how helpful do you think medica-
tions for TB are (not helpful, somehow helpful or very
helpful), and do you have barriers to take your medi-
cations as prescribed (yes or no), what do you think
is the cause of TB?’, respectively.
TB-related stigma
TB-related stigma was measured at the second assess-
ment using a 10-item TB stigma scale adapted from
Macq et al. (2006), translated into Amharic, and piloted
(Ambaw et al., 2015). In this sample, the scale had an
alpha value of 0.84 and a mean inter-item correlation
coefficient of 0.34. Scores were cut into three equal
parts and operationalized as low, moderate, and high
stigma.
Analyses
Data were analyzed using STATA version 15
(StataCorp. URL: http://www.stata.com). Descriptive
statistics were used to summarize variables and to
describe participants. Logistic regression was fitted
using generalized structural equation modelling
(GSEM) to identify the association between depression
and the dependent variables (diagnostic delay and
pathways to TB care) as well as the role of depression
as a mediator between other independent variables
and the dependent variables. The role of pathways to
TB care as a mediator between diagnostic delay and
all other independent variables including depression
was assessed the same way. GSEM allows modelling
categorical outcomes and generalized responses with-
out the need to fulfil the requirement of multivariate
normality (Rabe-Hesketh et al., 2004; StataCorp,
2017). The inclusion of independent variables in the
multivariable analysis was based on its theoretical
importance and adequacy of the number of partici-
pants in cells for each category (Tabachnic & Fidell,
2007). Because the study sites were located in two
regions of the country, clustered robust standard errors
were used. p values <0.05 were considered statistically
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significant. Associations have been reported using
odds ratios and beta (β) coefficients depending on the
availability of options for GSEM in STATA 15. The
Strengthening the Reporting of Observational Studies
in Epidemiology (STROBE) guidelines have been
used to report our findings (von Elm et al., 2007).
Results
Socio-demographic characteristics of the
participants
Just over half of the participants (n = 312; 52.7%) were
male, 444 (75.0%) had primary education or no formal
education and the median age of the participants was
30 years with range 18–85 years (Table 1).
Illnesses and substance use characteristics
Just over half of the participants (n = 313; 52.9%) had
probable depression. In total 445 (75.3%) perceived
that TB is a severe illness and only 82 (13.9%) per-
ceived that TB was caused by microorganisms. A
total of 62 (10.2%) were living with HIV. Moderate to
high risk of alcohol, khat and tobacco was reported
by 74 (12.5%), 96 (16.2%), and 29 (4.9%) of participants,
respectively (Table 2).
Diagnostic delay and pathways to TB care
The median delay to diagnosis was 12 weeks (range
0.3–520.0 weeks). A total of 512 (86.5%) participants
contacted the modern health care system directly.
The remaining 80 (13.5%) participants visited the trad-
itional health care system before contacting the modern
health care system where they had their illness diag-
nosed as TB (Table 2).
Factors associated with pathways to TB care and
diagnostic delay
There was no association between depression and
diagnostic delay (Adjusted odds ratio (AOR) = 0.90;
0.77, 1.06) or with pathways to TB care (adjusted β =
−0.45; 95% CI−1.85 to 0.96). Indirect pathways to TB
care (AOR = 2.72; 95% CI 1.25–5.91), male gender
(AOR = 1.62; 95% CI 1.39–2.02), absence of formal edu-
cation (AOR = 3.01; 95% CI 2.25–4.03), being a rural
resident (AOR = 1.67; 95% CI 1.49–1.88), being Muslim
(AOR = 1.57; 95% CI 1.29–1.92), having moderate
(AOR = 2.11; 95% CI 1.03–4.29) or severe disability
(AOR = 1.52; 95% CI 1.35–1.71), having extra-pulmonary
TB (AOR = 1.46; 95% CI 1.07–2.00), having higher
household income (AOR = 1.39; 95% CI 1.15–1.67),
and moderate- to- high risk of alcohol use (AOR =
1.34; 95% CI 1.14–1.57) were associated directly with
delay of diagnosis in people with TB. HIV positive
status (AOR = 0.81; 95% CI 0.67–0.99) and age group
50–85 years (AOR = 0.82; 95% CI 0.75–0.88) had inverse
relation with delaying diagnosis of TB.
Absence of formal education (adjusted β = 0.41; 95%
CI 0.14–0.67) or having just primary education
(adjusted β = 0.78; 95% CI 0.58–0.97), perceived social
Table 1. Socio-demographic characteristics of participants (n =
592)
Variable Number (%)
Sex
Male 312 (52.7)
Female 280 (47.3)
Age in years (mean = 33.8 ± 14; median = 30)
18–34 364 (61.5)
35–49 135 (22.8)
50–85 93 (15.7)
Marital status
Single 192 (32.4)
Married 329 (55.6)
Widowed or divorced 71 (12.0)
Level of education
No formal education 209 (35.3)
Primary education 235 (39.7)
Secondary or above 148 (25.0)
Occupation
Unemployed 35 (5.9)
Government employee 52 (8.8)
Self-employed 118 (19.9)
Farmer 159 (26.9)
Student 37 (6.3)
Housewife 105 (17.7)
Daily labourer 42 (7.1)
Other 44 (7.4)
Annual household income (median = 9366.00 Birr)
Below median 298 (50.3)
Median or above 294 (49.7)
Religion
Christian 387 (65.4)
Muslim 205 (34.6)
Residence
Urban 327 (55.2)
Rural 265 (44.8)
Ethnicity
Amhara 275 (46.5)
Gurage 176 (29.7)
Mareko 64 (10.8)
Silte 62 (10.5)
Oromo 9 (1.5)
Other 6 (1.0)
Perceived social support
Poor 244 (41.2)
Moderate 193 (32.6)
Strong 155 (26.2)
TB stigma score
Low 177 (29.9)
Moderate 232 (39.2)
High 183 (30.9)
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support (adjusted β = 0.36; 0.20–0.53), severe disability
(adjusted β = 1.86; 95% CI 1.68–2.05), higher household
income (adjusted β = 0.31; 95% CI 0.24–0.38), and
moderate- to- high risk of khat use (adjusted β = 1.12;
95% CI 0.92–1.31) were positively associated with diag-
nostic delay through increasing visits to the traditional
health care system before reaching modern care
facilities. On the other hand, rural residence (adjusted
β =−0.33; 95% CI −0.44 to −0.23), unknown HIV
status (adjusted β =−0.87; 95% CI −1.10 to −0.65),
and perceiving TB as a severe illness [adjusted
β =−0.93 (−1.21 to −0.65)] indirectly decreased
diagnostic delay through decreasing visits to the trad-
itional health care system (Table 3). The path diagram
of the analysis is shown in online Supplementary
Figure S1).
Discussion
None of our hypotheses was supported: co-morbid
depression was not associated with either diagnostic
delay or indirect pathways to TB care, and depression
did not appear to be a mediator of associations
between various socio-demographic and clinical fac-
tors and diagnostic delay or pathways to TB care.
There were no previous studies to compare our find-
ings. Two further factors require investigation before
we accept the null hypothesises of no difference.
First, only 71.0% of all estimated new TB cases in
Ethiopia are detected (World Health Organization,
2016). We do not know whether the undetected
29.0% of cases are different from 71.0% in terms of
depression status. Second, health extension workers
in the Ethiopian health care system encourage people
with TB symptoms to receive early diagnosis and treat-
ment by going from home-to-home (Workie &
Ramana, 2013). That means the role of depression in
influencing diagnosis delay may be reduced. Health
extension workers are more likely to help people
with TB symptoms when the symptoms are clear. For
example, we found that people with pulmonary TB
had shorter diagnosis delay compared to those with
extra-pulmonary TB where symptoms vary depending
on the site (Pallangyo, 2001).
Our findings suggest that depression may not have
any impact upon pathways to care for TB and the
knowledge of microorganisms as a cause for TB may
not be associated with where to go upon experiencing
symptoms. These findings generally agree with previ-
ous studies. In Ethiopia, the choice of a healer for an
illness largely depends on the reputation of the healer
in their community (Jakonsson, 1991) rather than the
symptoms felt or the perceived cause of the illness
(Keegstra, 1986). When people fail with one, they go
to another (Kloos et al., 1997).
Table 2. Illness, substance use and pathways to TB care (N = 592)
Variables Number (%)
Diagnosis delay in weeks
(median = 12; range = 0.3–520)
12 weeks or less 345 (58.3)
Above 12 weeks 247 (41.7)
Pathways to TB care
Direct (modern care) 512 (86.5)
Indirect (traditional care) 80 (13.5)
Probable depression
No 279 (47.1)
Yes 313 (52.9)
Type of TB
Pulmonary 340 (57.4)
Extra pulmonary 252 (42.6)
Perceived severity of TB
Mild to moderate 147 (24.8)
Severe 445 (75.2)
Perceived barriers to modern care
No 458 (77.4)
Yes 134 (22.6)
Perceived micro organism as a cause of TB
No 510 (86.2)
Yes 82 (13.9)
Perceived benefit of modern TB care
Not helpful 2 (0.30)
Somehow helpful 23 (3.9)
Helpful 567 (95.8)
HIV status
Negative 455 (76.9)
Positive 62 (10.5)
Unknown 75 (12.7)
Level of disability
Low or no disability 177 (29.9)
Moderate disability 231 (39.0)
High disability 184 (31.1)
Hypertension
No 591 (99.8)
Yes 1 (0.2)
Cardiac illness
No 590 (99.7)
Yes 2 (0.3)
Diabetes mellitus
No 587 (99.2)
Yes 5 (0.8)
Prior depression
No 592 (100)
Yes 0
Mental illness other than depression
No 592 (100.0)
Yes 0
Level of alcohol risk
Low 518 (87.5)
Moderate 66 (11.1)
High 8 (1.4)
Level of tobacco risk
Low 563 (95.1)
Moderate 27 (4.6)
High 2 (0.3)
Level of khat risk
Low 496 (83.8)
Moderate 87 (14.7)
High 9 (1.5)
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Table 3. Factors associated with pathways to TB care and diagnosis delay (n = 592)
Variables
Delay status
Diagnosis delay
AOR (95% CI)
Pathways to care
Adjusted β (95% CI)
No delay
Number (%)
Delay
Number (%)
Pathways to TB care
Direct (modern) 311 (60.7) 201 (39.3) 1
Indirect (traditional) 34 (42.5) 46 (57.5) 2.72 (1.25–5.91)
Presence of probable depression:
No 168 (60.2) 111 (39.8) 1 1
Yes 177 (56.6) 136 (43.5) 0.90 (0.77–1.06) −0.45 (−1.85 to 0.96)
Sex
Male 180 (57.7) 132 (42.3) 1.62 (1.39–2.02) 1
Female 165 (58.9) 115 (41.1) 1 0.21 (−0.42 to 0.84)
Age in years
18–34 226 (62.1) 138 (37.9) 1 1
35–49 70 (51.9) 65 (48.1) 1.14 (0.80–1.62) −0.05 (−0.83 to 0.74)
50–85 49 (52.7) 44 (47.3) 0.82 (0.75–0.88) −0.40 (−1.15 to 0.34)
Level of education
No formal education 95 (45.5) 114 (54.5) 3.01 (2.25–4.03) 0.41 (0.14–0.67)
Primary education 147 (62.6) 88 (37.4) 1.17 (0.77–1.77) 0.78 (0.58–0.97)
Secondary or above 103 (69.6) 45 (30.4) 1 1
Residence
Urban 214 (65.4) 113 (34.6) 1 1
Rural 131 (49.4) 134 (50.6) 1.67 (1.49–1.88) −0.33 (−0.44 to −0.23)
Marital status
Single 128 (66.7) 64 (33.3) 1 1
Married 182 (55.3) 147 (44.7) 1.07 (0.94–1.22) 0.08 (−0.11 to 0.28)
Widowed or divorced 35 (49.3) 36 (50.7) 1.70 (0.45–6.41) 0.46 (−0.43 to 1.35)
Religion
Christian 239 (61.8) 148 (38.2) 1 1
Muslim 106 (51.7) 99 (48.3) 1.57 (1.29–1.92) −1.77 (−4.36 to 0.81)
Perceived social support
Poor 141 (57.8) 103 (42.2) 1 1
Moderate 103 (53.4) 90 (46.6) 1.19 (0.85–1.67) 0.36 (0.20–0.53)
Strong 101 (65.2) 54 (34.8) 0.73 (0.30–1.76) 0.35 (−0.16 to 0.85)
TB stigma score
Low 105 (59.3) 72 (40.7) 1 1
Moderate 139 (59.9) 93 (40.1) 0.76 (0.50–1.15) 0.001 (−0.80 to 0.81)
High 101 (55.2) 82 (44.8) 0.73 (0.30–1.78) −0.31 (−0.91 to 0.29)
Level of disability
Low or no disability 121 (68.4) 56 (31.6) 1 1
Moderate disability 118 (51.1) 113 (48.9) 2.11 (1.03–4.29) 0.66 (−0.17 to 1.49)
Severe disability 106 (57.6) 78 (42.4) 1.52 (1.35–1.71) 1.86 (1.68–2.05)
Type of TB
Pulmonary 211 (62.1) 129 (37.9) 1 1
Extra pulmonary 134 (53.2) 118 (46.8) 1.46 (1.07–2.00) 0.01 (−0.74 to 0.77)
HIV status
Negative 260 (57.1) 195 (42.9) 1 1
Positive 42 (67.7) 20 (32.3) 0.81 (0.67–0.99) −0.40 (−2.17 to 1.37)
Unknown 43 (57.3) 32 (42.7) 1.24 (0.59–2.61) −0.87 (−1.10 to −0.65)
Annual household income
Below median 174 (58.4) 124 (41.6) 1 1
Median or above 171 (58.2) 123 (41.8) 1.39 (1.15–1.67) 0.31 (0.24–0.38)
(Continued)
global mental health
https://www.cambridge.org/core/terms. https://doi.org/10.1017/gmh.2019.17
Downloaded from https://www.cambridge.org/core. IP address: 83.240.178.190, on 23 Aug 2019 at 11:43:06, subject to the Cambridge Core terms of use, available at
Our findings that indirect pathway to TB care leads
to diagnostic delay agrees with the existing evidence
(Barker et al., 2006; Finnie et al., 2011). With all other
socio-demographic variables in this study kept con-
stant, better income was found to lead to diagnostic
delay both directly and indirectly by leading to indirect
pathways to TB care. Perceived good social support
also contributed to diagnosis delay through an increas-
ing visit to the traditional health care system. The
explanation why people with better income and sup-
port encounter a longer delay before diagnosis was
not clear. There is some evidence that traditional care
is much more expensive than the modern one
(Makanjuola, 2003). People with more resources may
be exploring more options of treatments for their
symptoms before accessing modern care. In Ethiopia,
modern TB care is totally free.
Our findings that the absence of formal education,
being a rural resident, having extra pulmonary TB,
and alcohol use are associated with diagnostic delay
agree with previous reports (Storla et al., 2008).
Contrary to previous reports (Storla et al., 2008;
Virenfeldt et al., 2014), HIV decreased diagnostic
delay in our study probably because people who
have known HIV status seek help more actively than
those without HIV; they are people who have already
sought help for HIV and been informed about poten-
tial symptoms of TB. The associations between gender,
age, religion, and residence and diagnosis delay and
pathways to TB care indicate the need for exploring
the underlying cultural drivers (Bailey, 1987). The asso-
ciation between disability and diagnosis delay may
show that people with a long period with illness
develop severe forms of disability or people with dis-
ability find it harder to access services (Virenfeldt
et al., 2014).
Limitations
We measured depression using a screening tool. We
also overly summarized pathways to care in to direct
and indirect without considering back and forth visits
or simultaneous use of both the traditional and con-
ventional health systems. People may not remember
exactly when the symptoms of TB started and, there-
fore, our estimates of diagnosis delay may not be
accurate. Our findings are generalisable only to people
with TB who were eventually attending the conven-
tional care regardless of their pathways; specifically,
it cannot be generalisable to those attending care in
the traditional care system only. Eighty-five per cent
of the sample reported to earn <1$/day/person
(Ambaw et al., 2017), and higher income and social
support are, therefore, only relative. Although there
might be a tendency to under report income, it might
not seriously affect regression outputs as those with
higher income are likely to report higher values than
those with lower income forming a pattern similar to
Table 3 (cont.)
Variables
Delay status
Diagnosis delay
AOR (95% CI)
Pathways to care
Adjusted β (95% CI)
No delay
Number (%)
Delay
Number (%)
Alcohol risk
Low 306 (59.1) 212 (40.9) 1
Moderate- to-high 39 (52.7) 35 (47.3) 1.34 (1.14–1.57) −1.18 (−3.98 to 1.62)
Khat risk
Low 298 (60.1) 198 (39.9) 1 1
Moderate- to-high 47 (49.0) 49 (51.0) 1.39 (0.58–3.30) 1.12 (0.92–1.31)
Microorganisms perceived as cause of
TB
No 296 (58.0) 214 (42.0) 1 1
Yes 49 (59.8) 33 (40.2) 1.32 (0.37–4.71) −0.27 (−0.91 to 0.37)
Perceived barriers to modern care
No 264 (57.6) 194 (42.4) 1
Yes 81 (60.5) 53 (39.5) 0.97 (0.77–1.21) −0.001 (−0.87 to 0.87)
Perceived severity of TB
Mild to moderate 89 (60.5) 58 (39.5) 1 1
Severe 256 (57.5) 189 (42.5) 0.95 (0.79–1.14) −0.93 (−1.21 to −0.65)
AOR, adjusted odds ratio.
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the correct value. The other limitation was the absence
of qualitative evidence on how each of the socio-
demographic factors was connected to pathways to
care and diagnosis delay.
Conclusions
People with TB who had co-morbid depression visited
the modern health care system as directly as and as
soon as people with TB who did not have co-morbid
depression. Depression was not mediating the relation-
ship between diagnostic delay and factors associated
with diagnostic delay. Co-morbid depression in people
with TB could be diagnosed and treated at TB clinics
by integrating mental health components into the TB
management protocol. This recommendation can be
used in other settings as well. How socio-demographic
factors influence pathways to care and diagnosis delay
require qualitative exploration.
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